← SynDRA
Nanvuranlat
SynDRA canonical compound SYN1973938 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SLC7A5 |
|---|
| Mechanism of action | solute carrier family member inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Kyt-0353
- KYT0353
- RefChem:164542
- JPH203
- JPH 203
- JPH203 free base
- CEDO9QXYZK
- UNII-CEDO9QXYZK
- MFCD30534398
- VRW
- NANVURANLAT [INN]
- C23H19Cl2N3O4
- GTPL9347
- orb1296219
- SCHEMBL17360639
- SCHEMBL29369044
- GLXC-10626
- EX-A2559
- JPH 203;
- BDBM50532381
- s8667
- AKOS032945064
- CS-6064
- NCGC00510750-01
- AC-36140
- BS-14324
- DA-64663
- JPH203 hydrochloride, >=98% (HPLC)
- HY-100868
- COMPOUND-JP [US20160279103]
- D71159
- SCHEMBL29657680
- CHEBI:231341
- KYT 0353 dihydrochloride
- HY-U00445
- orb1309522
- C23H21Cl4N3O4
- AKOS040733505
- Nanvuranlat dihydrochloride
Look up Nanvuranlat in the interactive SynDRA portal →